SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

OncoCyte (OCX)

OCX RSS Feed
Add OCX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/22/2016 9:35:27 PM - Followers: 7 - Board type: Free - Posts Today: 0
OncoCyte is a 76.39% owned subsidiary of BioTime, Inc (BTX)

OncoCyte is developing proprietary non-invasive tests using liquid biopsies (blood and urine) to help physicians improve the screening protocols for lung, breast and bladder cancer patients. OncoCyte’s portfolio of pipeline products detect biomarkers that are associated with specific types of cancer (lung, breast and bladder) to help physicians by confirming false positives to improve the standard of care and reduce overall health care spend.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OCX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
OCX News: Securities Registration Statement (s-1) 09/26/2016 05:31:22 PM
OCX News: Information Statement - All Other (definitive) (def 14c) 09/22/2016 04:02:35 PM
OCX News: OncoCyte Corporation to Present at the 2016 Aegis Growth Conference 09/20/2016 06:30:00 AM
OCX News: Proxy Statement - Other Information (preliminary) (pre 14c) 09/12/2016 06:02:46 AM
OCX News: Small Company Offering and Sale of Securities Without Registration (d) 09/09/2016 06:06:59 AM
News News Alert: Securities Registration Statement (s-1) 09/26/2016 05:31:22 PM